BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20919855)

  • 21. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Treatment of Follicular Lymphoma.
    Luminari S; Trotman J; Federico M
    Cancer J; 2020; 26(3):231-240. PubMed ID: 32496456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.
    Derenzini E; Casadei B; Broccoli A; Gandolfi L; Pellegrini C; Zinzani PL
    Br J Haematol; 2014 Aug; 166(4):625-8. PubMed ID: 24750128
    [No Abstract]   [Full Text] [Related]  

  • 24. Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience.
    Helbig G; Krawczyk-Kulis M; Kopinska A; Liwoch R; Kyrcz-Krzemien S
    Med Oncol; 2014 Dec; 31(12):310. PubMed ID: 25373321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Finalization of autologous stem cell transplant in complex and multirelapsed follicular lymphoma.
    Carella M; Stefoni V; Pellegrini C; Argnani L; Cavo M; Zinzani PL
    Tumori; 2020 Dec; 106(6):NP5-NP8. PubMed ID: 32442038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma.
    Arcaini L; Morello L; Tucci A; Rusconi C; Ladetto M; Rattotti S; Bonfichi M; Bottelli C; Gabutti C; Bernasconi P; Varettoni M; Gotti M; Troletti D; Guerrera ML; Fiaccadori V; Sciarra R; Ferretti VV; Alessandrino EP; Rossi G; Morra E
    Am J Hematol; 2015 Mar; 90(3):230-4. PubMed ID: 25502635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimising initial treatment for follicular lymphoma.
    Davies A
    Lancet Oncol; 2008 Apr; 9(4):309-11. PubMed ID: 18374284
    [No Abstract]   [Full Text] [Related]  

  • 28. Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world.
    Manna M; Lee-Ying R; Davies G; Stewart C; Oh DH; Peters A; Stewart DA
    Leuk Lymphoma; 2019 Jan; 60(1):133-141. PubMed ID: 29966465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASCT in follicular lymphoma.
    Brown JR; Freedman AS
    Nat Rev Clin Oncol; 2009 Jul; 6(7):380-2. PubMed ID: 19561632
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL).
    Rusconi C; Anastasia A; Chiarenza A; Marcheselli L; Cavallo F; Rattotti S; Botto B; Ferrari A; Nassi L; Pagani C; Meli E; Arcaini L; Federico M; Rossi G;
    Br J Haematol; 2019 May; 185(4):713-717. PubMed ID: 30793297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.
    Villa D; Crump M; Panzarella T; Savage KJ; Toze CL; Stewart DA; MacDonald DA; Buckstein R; Lee C; Alzahrani M; Rubinger M; Foley R; Xenocostas A; Sabloff M; Muccilli A; Chua N; Couture F; Larouche JF; Cohen S; Connors JM; Ambler K; Al-Tourah A; Ramadan KM; Kuruvilla J
    J Clin Oncol; 2013 Mar; 31(9):1164-71. PubMed ID: 23401459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
    Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma.
    Reddy N; Greer JP; Goodman S; Engelhardt B; Oluwole O; Jagasia MH; Savani BN
    Bone Marrow Transplant; 2012 Oct; 47(10):1318-20. PubMed ID: 22327132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy versus autologous stem-cell transplantation for the treatment of transformed follicular lymphoma in the rituximab era.
    Tam CS; Herschtal A; Dickinson M; George A; Seymour JF
    J Clin Oncol; 2013 Sep; 31(25):3166-7. PubMed ID: 23918946
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hematopoietic stem cell transplantation for malignant lymphoma].
    Asaoku H
    Nihon Rinsho; 2000 Mar; 58(3):704-8. PubMed ID: 10741150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma.
    Apostolidis J; Foran JM; Johnson PW; Norton A; Amess J; Matthews J; Bradburn M; Lister TA; Rohatiner AZ
    J Clin Oncol; 1999 Jan; 17(1):216-21. PubMed ID: 10458236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment strategies in follicular lymphomas: current status and future perspectives.
    Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Forstpointner R; Nickenig C; Unterhalt M
    J Clin Oncol; 2005 Sep; 23(26):6394-9. PubMed ID: 16155025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follicular lymphoma: managing an indolent malignancy.
    Hallam S; Montoto S
    Br J Hosp Med (Lond); 2010 May; 71(5):258-62. PubMed ID: 20448493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transformed follicular lymphoma (tFL): consolidation therapy may improve survival.
    Elhassadi E; Flavin R; Browne P; Conneally E; Hayden P; Quinn F; Higgins E; Vandenberghe E
    Ir J Med Sci; 2017 Aug; 186(3):589-595. PubMed ID: 28321641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.